A detailed history of Financial Freedom, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Freedom, LLC holds 544 shares of LLY stock, worth $499,392. This represents 0.25% of its overall portfolio holdings.

Number of Shares
544
Previous 503 8.15%
Holding current value
$499,392
Previous $293 Million 44.48%
% of portfolio
0.25%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $24,280 - $32,483
41 Added 8.15%
544 $423 Million
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $45,691 - $53,864
-87 Reduced 14.75%
503 $293 Million
Q3 2023

Nov 03, 2023

SELL
$434.7 - $599.3 $1,304 - $1,797
-3 Reduced 0.51%
590 $317 Million
Q2 2023

Jul 28, 2023

SELL
$350.74 - $468.98 $9,820 - $13,131
-28 Reduced 4.51%
593 $278 Million
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $621 - $729
2 Added 0.32%
621 $213 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $199,039 - $231,920
619 New
619 $227 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $872B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Freedom, LLC Portfolio

Follow Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Freedom, LLC with notifications on news.